RLYB Archived Articles
Rallybio (NASDAQ:RLYB): Navigating the Rare Disease Landscape with Innovation and Resilience
Published on March 11, 2025
Rallybio (RLYB): A Resilient Rare Disease Biotech Navigating Choppy Markets
Published on November 28, 2024
Rallybio Corporation (NASDAQ:RLYB): A Promising Rare Disease Biotech with Multiple Clinical-Stage Assets
Published on September 24, 2024